In vitro antibacterial activities of crude extracts of Garcinia kola seeds against wound sepsis associated Staphylococcus strains

Journal of Medicinal Plants Research

Volumn 4, Issue 8, 2010, Pages 710-716

  Sibanda, T ^a   Olaniran, A O ^b   Okoh, A I ^a  

^a UNIVERSITY OF FORT HARE   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Antibiotic potentiation; Antistaphylococcal activity; Garcinia kola; Staphylococcus; Wound sepsis

Indexed keywords

ACETONE; AMOXICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; DNA 16S; ERYTHROMYCIN; GARCINIA KOLA EXTRACT; METHANOL; PENICILLIN G SODIUM; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA SEQUENCE; DRUG EXPOSURE; DRUG POTENTIATION; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANT SEED; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS SCIURI; STRAIN DIFFERENCE; WOUND INFECTION;

GARCINIA KOLA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS SCIURI;

EID: 77951926565     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Afolayan AJ, Meyer JJM (1997). The antimicrobial activity of 3,5,7- trihydroxyflavone isolated from the shoots of Helichrysum aureonitens. J. Ethnopharm. 57(3): 177-181.
2. Akinpelu DA, Onakoya TM (2006). Antimicrobial activities of medicinal plants used in folklore remedies in south-western Nigeria. Afr. J. Biotech. 5(11): 1078-1081.
3. Al-hebshi N, Al-haroni M, Skaug N (2006). In vitro antimicrobial and resistance-modifying activities of aqueous crude khat extracts against oral microorganisms. Arch. Oral Biol. 51: 183-188.
4. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997). Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25: 3389-3402.
5. Archer GL (1998). Staphylococcus aureus: A well-armed pathogen. Clin. Inf. Dis. 26: 1179-1180.
6. Basri DF, Fan SH (2005). The potential of aqueous and acetone extracts of galls of Queercus infectoria as antibacterial agents. Ind. J. Pharm. 37: 26-29.
7. Braga LC, Leite AAM, Xavier KGS, Takahashi JA, Bemquerer MP, Chartone-Souza E, Nascimento AMA (2005). Synergic interaction between pomegranate extract and antibiotics against Staphylococcus aureus. Canad. J. Microbiol. 51(7): 541-547.
8. British Society for Antimicrobial Chemotherapy (BSAC), European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2005). Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests: pp. 1-21.
9. Cook N (1998). Methicillin resistant Staphylococcus aureus versus the burn patient. Burns 24: 91-98.
10. Darwish RM, Aburjai T, Al-Khalil S, Mahafzah A (2002). Screening of antibiotic resistant inhibitors from local plant materials against two different strains of Staphylococcus aureus. J. Ethnopharm. 79: 359-364.
11. Den-Hollander JG, Horrevorts AM, Van Goor MPJ, Verbrugh HA, Mouton JW (1997). Synergism between tobramycin and ceftazidime against a resistant pseudomonas aeruginosa strain, tested in an in vitro Pharmacokinetic Model. Antimic. Agents Chemo. 41(1): 95-100.
12. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS (2003). Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin. Inf. Dis. 36: 592-598.
13. European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2003). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. Micro. Inf. 9(8): 1-7.
14. European Committee for Antimicrobial SusceptibilityTesting (EUCAST) (2000b). Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin. Micro. Inf. 6(9): 503-508.
15. European Committtee for Antimicrobial Susceptibity Testing (EUCAST) (2000a). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin. Micro. Inf. 6(9): 509-515.
16. Han QB, Lee SF, Qiao CF, He ZD, Song JZ, Sun HD, Xu HX (2005). Complete NMR assignments of the antibacterial biflavonoid GB1 from Garcinia kola. Chem. Pharm. Bull. 53(8): 1034-1036.
17. Holden MTG, Feil EJ, Lindsay JA, Peacock SJ, Day NPJ, Enright MC, Foster TJ, Moore CE, Hurst L, Atkin R, Barron A, Bason N, Bentley SD, Chillingworth C, Chillingworth T, Churcher C, Clark L, Corton C, Cronin A, Doggett J, Dowd L, Feltwell T, Hance Z, Harris B, Hauser H, Holroyd S, Jagels K, James KD, Lennard N, Line A, Mayes R, Moule S, Mungall K, Ormond D, Quail MA, Rabbinowitsch E, Rutherford K, Mandy Sanders KM, Sharp S, Simmonds M, Kim Stevens K, Whitehead S, Bart G, Barrell BG, Brian G, Spratt BG, Parkhill J (2004). Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance. PNAS. 101(26): 9786-9791.
18. Iwu MW, Duncan AR, Okunji CO (1999). New antimicrobials of plant origin. J. Janick (ed.), Perspectives on new crops and new uses pp. 457-462.
19. Lee JY, Oh WS, Ko KS, Heo ST, Moon CS, Ki HK, Kiem S, Peck KR, Song JH (2006). Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus. J. Korean Med. Sci. 21: 188-192.
20. Lowy DF (2003). Antimicrobial resistance: the example of Staphylococcus aureus. J. Clin. Invest. 111: 1265-1273.
21. Madubunyi II (1995). Antimicrobial activities of the constituents of Garcinia kola seeds. Int. J. Pharmacog. 33(3): 232-237.
22. Marchesi JR, Sato T, Weightman AJ, Martin TA, Fry JC, Hiom SJ, Dymock D, Wade WG (1998). Design and evaluation of useful bacterium specific PCR primers that amplify genes coding for 16S rRNA. Appl. Environ. Microbiol. 64: 795-799.
23. Marsou R, Bes M, Boudouma M, Brun Y, Meugnier H, Freney J, Vandenesch F, Etienne J (1999). Distribution of Staphylococcus sciuri subspecies among human clinical specimens, and profile of antibiotic resistance. Res. Microbiol. 150(8): 531-541.
24. Moran GJ, Amii RN, Abrahamian FM, Talan DA (2005). Methicillin- resistant Staphylococcus aureus in Community acquired Skin Infections. Emerg. Inf. Dis. 11(6): 928-930.
25. Neugebauer KA, Gilliland SE (2005). Antagonistic action of Lactobacillus delbrueckii ssp. lactis RM2-5 toward spoilage Organisms in cottage cheese. J. Dairy Sci. 88: 1335-1341.
26. Nostro A, Cannatelli MA, Grisafi G, Alonszo V (2001). The effect of Nepata cataria extract on adherence and enzyme production of Staphylococcus aureus. Int. J. Antimicrob. Agents. 18: 583-585.
27. Okoli S, Iroegbu CU (2005). In vitro antibacterial activity of Synclisa scabrida whole root extracts. Afr. J. Biotech. 4(9): 946-952.
28. Oliveira FP, Lima EO, Siqueira Junior JP, Souza EL, Santos BHC, Barreto HM (2006). Effectiveness of Lippia sidoides Cham. (Verbenaceae) essential oil in inhibiting the growth of Staphylococcus aureus strains isolated from clinical material. Rev. Bras. Farmacogn. 16(4): 510-516.
29. Palombo EA, Semple SJ (2002). Antibacterial activity of Australian plant extracts against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). J. Basic Micro. 42(6): 444-448.
30. Pankey G, Ashcraft D, Patel N (2005). In vitro Synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Antimic. Agents Chemo. 49(12): 5166-5168.
31. Pankey GA, Ashcraft DS (2005). In vitro Synergy of Ciprofloxacin and Gatifloxacin against Ciprofloxacin-Resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49(7): 2959-2964.
32. Rello J, Torres A, Ricart M, Valles J, Gonzalez J, Artigas A, Rodriguez-Roisin R (1994). Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am. J. Respir. Crit. Care Med. 150(6): 1545-1549.
33. Rios JL, Recio MC (2005). Medicinal plants and antimicrobial activity. J. Ethnopharm. 100: 80-84.
34. Samie A, Obi CL, Bessong PO, Namrita L (2005). Activity profiles of fourteen selected medicinal plants from Rural Venda communities in South Africa against fifteen clinical bacterial species. Afr. J. Biotech. 4(12): 1443-1451.
35. Schwarz S, Kehrenberg C, and Ojo KK (2002). Staphylococcus sciuri Gene erm (33), encoding inducible resistance to macrolides, lincosamides, and streptogramin B antibiotics, is a product of recombination between erm(C) and erm(A). Antimic. Agents Chemo. 46(11): 3621-3623.
36. Stepanovic S, Dakic I, Martel A, Vaneechoutte M, Morrison D, Shittu A, Jezek P, Decostere A, Devriese LA, and Haesebrouck F (2005). A comparative evaluation of phenotypic and molecular methods in the identification of members of the Staphylococcus sciuri group. Syst. Appl. Micro. 28(4): 353-357.
37. Stepanovic S, Dimitrijevic V, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M (2001). Staphylococcus sciuri as a part of skin, nasal and oral flora in healthy dogs. Vet. Micro. 82(2): 177-185.
38. Styers D, Sheehan DJ, Hogan P, Sahm DF (2006). Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann. Clin. Micro. Antim. 5: 2.
39. Tenover FC, Weigel LM, Appelbaum PC, McDougal LK, Chaitram J, McAllister S, Clark N, Killgore G, O'Hara CM, Jevitt L, Patel JB, Bozdogan B (2004). Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimic. Agents Chemo. 48(1): 275-280.
40. Voravuthikunchai SP, Kitpipit L (2005). Activity of medicinal plant extracts against hospital isolates of methicillin-resistant Staphylococcus aureus. Clin. Micro. Inf. 11(6): 510-512.
41. White RL, Burgess DS, Manduru M, Bosso JA (1996). Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimic. Agents Chemo. 40(8): 1914-1918.
42. Wilson P, Andrews JA, Charlesworth R, Walesby R, Singer M, Farrell DJ, Robbins M (2003). Linezolid resistance in clinical isolates of Staphylococcus aureus. J. Antimic. Chemo. 51: 186-188.
43. Yang ZC, Wang BC, Yang XS, Wang Q, Ran L (2005). The synergistic activity of antibiotics combined with eight traditional Chinese medicines against two different strains of Staphylococcus aureus. Colloids and surfaces B. Biointerfaces. 41(2-3): 79-81.